Loading…
Mangalam Drugs and Organics (MANGALAM)₹29.22−1.72%Pharmaceuticals
At the end of the Jun 2026 quarter, Mangalam Drugs and Organics' shareholders were: promoters 35.61%, FIIs 0.11%, public 64.28%. Promoter holding is unchanged on the quarter. FII holding is down 0.42 percentage points from 0.53% a year earlier. It had 24,476 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 50.27% | 50.27% | 50.27% | 50.27% | 50.26% | 50.26% | 50.26% | 50.26% | 50.26% | 35.60% | 35.61% | 35.61% |
| FIIs | 0.10% | 0.10% | 0.26% | 0.21% | 0.11% | 0.11% | 0.47% | 0.53% | 0.11% | 0.13% | 0.32% | 0.11% |
| Public | 49.63% | 49.63% | 49.47% | 49.52% | 49.63% | 49.63% | 49.27% | 49.21% | 49.63% | 64.27% | 64.07% | 64.28% |
| Number of shareholders | 17,986 | 18,618 | 19,181 | 19,320 | 19,516 | 19,687 | 19,705 | 19,736 | 19,890 | 21,236 | 25,151 | 24,476 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Shree Rasbihari Trading & Investment Pvt Ltd | Promoter | 6.25% | 0.00 |
| Shri Jb Pharma Private Limited | Promoter | 6.04% | 0.00 |
| Dhoot Goverdhan Murlidhar | Promoter | 3.25% | 0.00 |
| Shree Kishoriju Trading & Investment Pvt Ltd | Promoter | 3.24% | 0.00 |
| Brijmohan Murlidhar Dhoot - 2 | Promoter | 3.07% | +2.58 |
| Shweta Goverdhan Dhoot | Promoter | 2.58% | 0.00 |
| Radhika Ajay Dhoot | Promoter | 1.87% | 0.00 |
| Smita Aditya Dhoot | Promoter | 1.84% | 0.00 |
| Rajkumari R. Dhoot | Promoter | 1.72% | 0.00 |
| Raj Exports Pvt Ltd | Promoter | 1.20% | 0.00 |
| Thakkalapalli Sampath Rao | Public | 1.04% | 0.00 |
| Anish Dwivedi | Public | 1.02% | New |
| Govardhan Murlidhar Dhoot | Promoter | 0.97% | 0.00 |
| Rekha Goverdhan Dhoot | Promoter | 0.93% | 0.00 |
| Ajay Ramniwas Dhoot | Promoter | 0.88% | 0.00 |
| Jyoti Brijmohan Dhoot | Promoter | 0.66% | 0.00 |
| Aditya R Dhoot | Promoter | 0.56% | 0.00 |
| Brijmohan Murlidhar Dhoot | Promoter | 0.49% | −2.62 |
| Rajkamal Sukhani | Promoter | 0.18% | 0.00 |
Promoters held 35.61% of Mangalam Drugs and Organics at the end of the Jun 2026 quarter, down 14.65 percentage points from 50.26% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.11% (down 0.21 percentage points from 0.32% a quarter earlier) and domestic institutions (DIIs) held no reported stake.
Mangalam Drugs and Organics had 24,476 shareholders at the end of the Jun 2026 quarter, against 19,736 a year earlier.
Thakkalapalli Sampath Rao (Public) held 1.04% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.